Regenxbio (RGNX) Enterprise Value (2014 - 2025)
Regenxbio (RGNX) recorded quarterly Enterprise Value of -$230.1 million in Q4 2025, up 16.1% quarter-over-quarter from -$274.2 million in Q3 2025, and up 1.97% on a YoY basis from -$225.6 million in Q4 2024.
Regenxbio (RGNX) Enterprise Value (2014 - 2025) Analysis & Trends
Regenxbio's Enterprise Value history runs 12 years deep, the most recent figure standing at -$230.1 million for Q4 2025.
- In Q4 2025, Enterprise Value rose 1.97% year-over-year to -$230.1 million; the TTM figure through Dec 2025 stood at -$230.1 million (up 1.97% YoY), while the FY2025 annual figure was -$230.1 million, up 1.97% from the prior year.
- Enterprise Value was -$230.1 million for Q4 2025 at Regenxbio, up from -$274.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$230.1 million in Q4 2025 to a low of -$457.4 million in Q4 2021.
- Historically, Enterprise Value has averaged -$330.0 million across 5 years, with a median of -$327.6 million in 2023.
- The sharpest annual moves came in 2021 and 2023: Enterprise Value plunged 57.88% in 2021, then climbed 24.51% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$457.4 million in 2021, then increased by 20.29% to -$364.6 million in 2022, then gained by 24.51% to -$275.3 million in 2023, then grew by 14.74% to -$234.7 million in 2024, then grew by 1.97% to -$230.1 million in 2025.
- The last three Enterprise Value figures came in at -$230.1 million (Q4 2025), -$274.2 million (Q3 2025), and -$323.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | -230.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -230.07 Mn |
| Sep 30, 2025 | -274.21 Mn |
| Jun 30, 2025 | -323.30 Mn |
| Mar 31, 2025 | -267.87 Mn |
| Dec 31, 2024 | -234.69 Mn |
| Sep 30, 2024 | -255.46 Mn |
| Jun 30, 2024 | -290.36 Mn |
| Mar 31, 2024 | -338.70 Mn |
| Dec 31, 2023 | -275.26 Mn |
| Sep 30, 2023 | -301.89 Mn |
| Jun 30, 2023 | -320.08 Mn |
| Mar 31, 2023 | -331.82 Mn |
| Dec 31, 2022 | -364.64 Mn |
| Sep 30, 2022 | -382.42 Mn |
| Jun 30, 2022 | -402.96 Mn |
| Mar 31, 2022 | -394.13 Mn |
| Dec 31, 2021 | -457.44 Mn |
| Sep 30, 2021 | -339.86 Mn |
| Jun 30, 2021 | -374.74 Mn |
| Mar 31, 2021 | -440.88 Mn |